Executive Committee: Peptron, Inc.

Manager
Positions heldSince
Ho-Il Choi

Ho-Il Choi

58 year

Chief Executive Officer 1997-11-20
Seung-Gu Jang

Seung-Gu Jang

58 year

Director of Finance/CFO 1999-06-30
Gi-Young Lee

Gi-Young Lee

59 year

Comptroller/Controller/Auditor 2017-03-26
Min-Ho Song

Min-Ho Song

63 year

Chief Executive Officer 2021-03-29

Composition of the Board of Directors: Peptron, Inc.

Director
CommitteesSince
Ho-Il Choi

Ho-Il Choi

58 year

Chairman
Min-Ho Song

Min-Ho Song

63 year

Director/Board Member 2021-03-29
Sang-Heon Lee

Sang-Heon Lee

57 year

Director/Board Member
Hyo-Seop Kim

Hyo-Seop Kim

53 year

Director/Board Member 2015-06-30
Young-Go Jung

Young-Go Jung

49 year

Director/Board Member 2014-03-30
Independent Dir/Board Member 2014-03-30
Seung-Gu Jang

Seung-Gu Jang

58 year

Director/Board Member 1999-06-30

Former Officers and Directors: Peptron, Inc.

Insider
Positions held
SinceUntil
Sang-Cheol Kim
Sang-Cheol Kim
Director/Board Member 2015-03-30 2016-05-10
Director of Finance/CFO 2015-03-30 2016-05-10
Hee-Yong Lee
Hee-Yong Lee
Director/Board Member 2015-03-30 2016-05-10
Chief Tech/Sci/R&D Officer 2015-03-30 2016-05-10
Joon-Shik Kim
Joon-Shik Kim
Chief Tech/Sci/R&D Officer 2006-06-30 -
Min-Gyoo Seong
Min-Gyoo Seong
Comptroller/Controller/Auditor 2003-12-31 -
Jong-Il Park
Jong-Il Park
Director/Board Member 2011-09-29 -
Eun-Yeong Seol
Eun-Yeong Seol
Corporate Officer/Principal 2011-09-29 -
Doo-Shin Park
Doo-Shin Park
Corporate Officer/Principal 2011-09-29 -
Dong-Hee Lee
Dong-Hee Lee
Corporate Officer/Principal 2011-09-29 -
Gook-Hyun Kyung
Gook-Hyun Kyung
Director/Board Member - -
Independent Dir/Board Member - -
Sun-Kyu Choi
Sun-Kyu Choi
Director/Board Member - -

Age distribution of managers

Parity Men Women

Male 7
Female 0

Of which Executive Committee

Male 4
Female 0

Of which Directors

Male 6
Female 0
ESG Refinitiv
-
Logo Peptron, Inc.
Peptron, Inc. is a Korea-based company principally engaged in the development, manufacture and distribution of sustained-release medications. The Company mainly produces peptides as drug materials mainly for prostate cancer, hyperpituitarism, diabetes and neurodegenerative disorders. The Company also provides peptide synthesis services. The Company manufactures raw material medicines and some functional cosmetics. The Company distributes its products within domestic market and to overseas markets.
Employees
0
More about the company
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW